A multicenter, Randomized, Open-Label Phase 3 Study to I

Project: Research project

Project Details

Description

A multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects with Metastic, Locally Advanced,
StatusFinished
Effective start/end date9/16/1412/31/18

Funding

  • CYTRX